- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2/Neu-positive Breast Cancer in South Africa
Total 757 results
-
SCRI Development Innovations, LLCEli Lilly and Company; Celgene CorporationCompletedBreast CancerUnited States
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States, Argentina, Australia, Brazil, Korea, Republic of, Mexico, Puerto Rico, Taiwan
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States, South Africa
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Poland
-
University Hospital OstravaUniversity of Ostrava; Silesian Hospital in Opava; Masaryk Memorial Cancer Institute and other collaboratorsCompleted
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
International Agency for Research on CancerBarretos Cancer Hospital; Instituto Nacional de Salud Publica, Mexico; University... and other collaboratorsRecruitingBreast Cancer FemaleChile, Colombia, Brazil, Costa Rica, Mexico
-
Hoosier Cancer Research NetworkUnited States Department of Defense; Indiana University School of Medicine; Walther...TerminatedBreast CancerUnited States, Peru
-
EMD SeronoTerminatedBreast CancerCzech Republic, Korea, Republic of, Russian Federation, South Africa, Germany, Slovakia, Austria, United States, Belgium, Poland, Israel, Australia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel, Spain, Australia, Canada, New Zealand, United Kingdom, France, Tunisia
-
Eli Lilly and CompanyCompleted
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
DualityBio Inc.RecruitingHER2-positive Advanced Solid TumorChina, United States, Australia, Puerto Rico
-
Konica Minolta Medical Imaging, USACompletedBreast CancerUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBreast CancerUnited States, South Africa, Canada, Argentina, Chile, Bulgaria, Croatia, Netherlands, Estonia, Denmark, Poland, Brazil, Mexico, Romania
-
Eli Lilly and CompanyGenentech, Inc.CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Case Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
-
University of SydneyCompletedBreast CancerAustralia
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Hoosier Cancer Research NetworkPurdue University; Indiana University School of MedicineCompletedBreast CancerUnited States
-
SCRI Development Innovations, LLCSanofiCompleted
-
Novartis PharmaceuticalsTerminated
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
NRG OncologyNational Cancer Institute (NCI)SuspendedStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
AgendiaCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
Alaunos TherapeuticsCompletedBreast Cancer Nos Metastatic RecurrentUnited States
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Hoosier Cancer Research NetworkNovartis Pharmaceuticals; Walther Cancer InstituteTerminated
-
Novartis PharmaceuticalsCompletedBreast CancerSaudi Arabia, Argentina, Belgium, Spain, Italy, Korea, Republic of, South Africa, France, Netherlands
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Genentech, Inc.No longer availableMetastatic Breast CancerUnited States
-
Nuvation Bio Inc.TerminatedGlioma | Breast Cancer | Glioblastoma | Advanced Breast Cancer | Prostate Cancer | Metastatic Breast Cancer | Recurrent Glioblastoma | Breast Carcinoma | Castration-resistant Prostate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Glioma, Malignant | Cancer of Breast | Malignant Tumor of Breast and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
AstraZenecaCompletedBreast CancerUnited States, South Africa, Spain, France, Netherlands, United Kingdom, Greece, Canada
-
South Tyneside and Sunderland NHS Foundation TrustUnknownCentral Venous Cather PositionUnited Kingdom